Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis

12 Jan 2024

Abstract excerpt

X-ray repair cross-complementation group 1 (XRCC1) is a pivotal contributor to base excision repair, and its dysregulation has been implicated in the oncogenicity of various human malignancies. However, a comprehensive pan-cancer analysis investigating the prognostic value, immunological functions, and epigenetic associations of XRCC1 remains lacking. To address this knowledge gap, we conducted a systematic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38217545
DOI: 10.18632/aging.205426

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysisPMID 38217545Read ↗

Multiomics analysis of homologous recombination deficiency across cancer types.Semantic proximity Read ↗

A multidimensional analysis of RAD1 as an immunological and prognostic biomarker in BRCASemantic proximity Read ↗

X-ray cross-complementing family: the bridge linking DNA damage repair and cancerSemantic proximity Read ↗

A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancerSemantic proximity Read ↗

A pan-cancer analysis of the oncogenic role of ERCC6LSemantic proximity Read ↗

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Semantic proximity Read ↗

Pan-cancer analysis of tumor mutational burden and homologous recombination DNA damage repair by targeted next-generation sequencingSemantic proximity Read ↗

A comprehensive pan-cancer analysis identifies AP1S1 as a novel biomarker for predicting prognosis and immunotherapy responseSemantic proximity Read ↗

A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic PredictionSemantic proximity Read ↗

Comprehensive Bioinformatics Investigation of RAD51C in Cervical Cancer: Expression, Prognostic Significance, DNA methylation, Immune Infiltration, Immune Checkpoint Correlation, and Functional Network AnalysisSemantic proximity Read ↗

The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response.Semantic proximity Read ↗

Association of ERCC family mutations with prognosis and immune checkpoint inhibitors response in multiple cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.